The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to deter...
| Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Publication Date: | 2023 |
| Country: | España |
| Institution: | Universitat Autònoma de Barcelona |
| Repository: | Dipòsit Digital de Documents de la UAB |
| Language: | English |
| OAI Identifier: | oai:ddd.uab.cat:319576 |
| Online Access: | https://ddd.uab.cat/record/319576 https://dx.doi.org/urn:doi:10.3390/ijms241311183 |
| Access Level: | Open access |
| Keyword: | High-grade serous ovarian carcinoma Early stage PD-L1 BRCA TMB |
| id |
ES_fb52f8ca5ab11cf591bedb60caddf393 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:319576 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)Pizarro, DavidRomero, IgnacioPérez-Mies, BelénRedondo Sánchez, Andrés|||0000-0002-7257-5642Caniego-Casas, TamaraCarretero-Barrio, Irene|||0000-0003-1986-2965Cristóbal, EvaGutiérrez-Pecharromán, AnaSantaballa, Ana|||0000-0001-7763-320XD'Angelo, Emanuela|||0000-0002-6173-1806Hardisson, David|||0000-0002-2183-3699Vieites, BegoñaMatías-Guiu, Xavier|||0000-0002-7201-6605Estévez-García, PurificaciónGuerra, Eva|||0000-0003-1910-4451Prat, Jaime|||0000-0002-9787-3304Poveda, AndrésLópez-Guerrero, J.A.|||0000-0002-7369-8388Palacios, José|||0000-0002-6730-5066High-grade serous ovarian carcinomaEarly stagePD-L1BRCATMBEarly stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to determine the prognostic significance of CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), tumoral cell PD-L1 expression, BRCA mutational status and tumor mutation burden (TMB) in early-stage HGSOC. A retrospective study was performed on stage I and II HGSOC from the Molecular Reclassification of Early Stages of Ovarian Cancer (RECLAMO) cohort from the Spanish Group of Ovarian Cancer Research (GEICO). Centralized histological typing was performed based on morphological and immunohistochemical features. Intraepithelial (i) and stromal (s) CD8+ and CD4+ T cells and PD-L1 were evaluated on tissue microarrays by immunohistochemistry. BRCA1 and BRCA2 mutation status and TMB were analyzed in tumor DNA using next-generation sequencing. The study included 124 tumors. High iCD8+ (. 22023-01-0120232023-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/319576https://dx.doi.org/urn:doi:10.3390/ijms241311183reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengInstituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/01331Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI22/01892Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PMP22/00054Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CB16/12/00316European Development Regional Fund 'A way to achieve Europe' (FEDER) CB16/12/00316Spanish Group of Research in Ovarian Cancer (GEICO group) CB16/12/00316Spanish Association Against Cancer Scientific Foundation (AECC) CB16/12/00316open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3195762026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| title |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| spellingShingle |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) Pizarro, David High-grade serous ovarian carcinoma Early stage PD-L1 BRCA TMB |
| title_short |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| title_full |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| title_fullStr |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| title_full_unstemmed |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| title_sort |
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO) |
| dc.creator.none.fl_str_mv |
Pizarro, David Romero, Ignacio Pérez-Mies, Belén Redondo Sánchez, Andrés|||0000-0002-7257-5642 Caniego-Casas, Tamara Carretero-Barrio, Irene|||0000-0003-1986-2965 Cristóbal, Eva Gutiérrez-Pecharromán, Ana Santaballa, Ana|||0000-0001-7763-320X D'Angelo, Emanuela|||0000-0002-6173-1806 Hardisson, David|||0000-0002-2183-3699 Vieites, Begoña Matías-Guiu, Xavier|||0000-0002-7201-6605 Estévez-García, Purificación Guerra, Eva|||0000-0003-1910-4451 Prat, Jaime|||0000-0002-9787-3304 Poveda, Andrés López-Guerrero, J.A.|||0000-0002-7369-8388 Palacios, José|||0000-0002-6730-5066 |
| author |
Pizarro, David |
| author_facet |
Pizarro, David Romero, Ignacio Pérez-Mies, Belén Redondo Sánchez, Andrés|||0000-0002-7257-5642 Caniego-Casas, Tamara Carretero-Barrio, Irene|||0000-0003-1986-2965 Cristóbal, Eva Gutiérrez-Pecharromán, Ana Santaballa, Ana|||0000-0001-7763-320X D'Angelo, Emanuela|||0000-0002-6173-1806 Hardisson, David|||0000-0002-2183-3699 Vieites, Begoña Matías-Guiu, Xavier|||0000-0002-7201-6605 Estévez-García, Purificación Guerra, Eva|||0000-0003-1910-4451 Prat, Jaime|||0000-0002-9787-3304 Poveda, Andrés López-Guerrero, J.A.|||0000-0002-7369-8388 Palacios, José|||0000-0002-6730-5066 |
| author_role |
author |
| author2 |
Romero, Ignacio Pérez-Mies, Belén Redondo Sánchez, Andrés|||0000-0002-7257-5642 Caniego-Casas, Tamara Carretero-Barrio, Irene|||0000-0003-1986-2965 Cristóbal, Eva Gutiérrez-Pecharromán, Ana Santaballa, Ana|||0000-0001-7763-320X D'Angelo, Emanuela|||0000-0002-6173-1806 Hardisson, David|||0000-0002-2183-3699 Vieites, Begoña Matías-Guiu, Xavier|||0000-0002-7201-6605 Estévez-García, Purificación Guerra, Eva|||0000-0003-1910-4451 Prat, Jaime|||0000-0002-9787-3304 Poveda, Andrés López-Guerrero, J.A.|||0000-0002-7369-8388 Palacios, José|||0000-0002-6730-5066 |
| author2_role |
author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
High-grade serous ovarian carcinoma Early stage PD-L1 BRCA TMB |
| topic |
High-grade serous ovarian carcinoma Early stage PD-L1 BRCA TMB |
| description |
Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to determine the prognostic significance of CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), tumoral cell PD-L1 expression, BRCA mutational status and tumor mutation burden (TMB) in early-stage HGSOC. A retrospective study was performed on stage I and II HGSOC from the Molecular Reclassification of Early Stages of Ovarian Cancer (RECLAMO) cohort from the Spanish Group of Ovarian Cancer Research (GEICO). Centralized histological typing was performed based on morphological and immunohistochemical features. Intraepithelial (i) and stromal (s) CD8+ and CD4+ T cells and PD-L1 were evaluated on tissue microarrays by immunohistochemistry. BRCA1 and BRCA2 mutation status and TMB were analyzed in tumor DNA using next-generation sequencing. The study included 124 tumors. High iCD8+ (. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2 2023-01-01 2023 2023-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/319576 https://dx.doi.org/urn:doi:10.3390/ijms241311183 |
| url |
https://ddd.uab.cat/record/319576 https://dx.doi.org/urn:doi:10.3390/ijms241311183 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/01331 Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI22/01892 Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PMP22/00054 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CB16/12/00316 European Development Regional Fund 'A way to achieve Europe' (FEDER) CB16/12/00316 Spanish Group of Research in Ovarian Cancer (GEICO group) CB16/12/00316 Spanish Association Against Cancer Scientific Foundation (AECC) CB16/12/00316 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869425318671941632 |
| score |
15.811543 |